Formula Growth’s KEMET Corporation KEM Stock Holding History

Formula Growth’s Portfolio KEM Stock Details KEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-175,000	Closed	-$3.18M	–	160
2019 Q3	$3.18M	Buy	+175,000	New	+$3.3M	0.48%	58

Other funds holding KEM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Formula Growth's KEM Position: Q4 2019 in Review

Formula Growth sold out of KEMET Corporation (KEM) in Q4 2019, closing a stake of 175,000 shares — an estimated $3.18M sold.

Formula Growth first reported a position in KEM in Q3 2019 and held it in 1 quarter. The position peaked at $3.18M in Q3 2019. 204 funds tracked by Wall St. Rank hold KEM as of Q4 2019.

Formula Growth reported no remaining KEMET Corporation position as of Q4 2019 after selling out during the quarter.
Formula Growth sold 175,000 KEMET Corporation shares in Q4 2019, an estimated $3.18M.
Formula Growth first reported a position in KEMET Corporation in Q3 2019 and held it in 1 quarter.
Formula Growth's KEMET Corporation position peaked at $3.18M in Q3 2019.
204 funds tracked by Wall St. Rank held KEMET Corporation as of Q4 2019.

Based on Formula Growth's 13F filing for Q4 2019, filed 13 Feb 2020.